Addgene: pLKO.1 puro shRNA beta-catenin Citations

pLKO.1 puro shRNA beta-catenin Citations (20)

Originally described in: Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways.
Onder TT, Gupta PB, Mani SA, Yang J, Lander ES, Weinberg RA Cancer Res. 2008 May 15. 68(10):3645-54. PubMed Journal

Articles Citing pLKO.1 puro shRNA beta-catenin

Showing 1 to 10 of 20 entries

Show entries

Search table:

Articles
Genome-scale CRISPR-Cas9 screen of Wnt/beta-catenin signaling identifies therapeutic targets for colorectal cancer. Wan C, Mahara S, Sun C, Doan A, Chua HK, Xu D, Bian J, Li Y, Zhu D, Sooraj D, Cierpicki T, Grembecka J, Firestein R. Sci Adv. 2021 May 19;7(21). pii: 7/21/eabf2567. doi: 10.1126/sciadv.abf2567. Print 2021 May. PubMed
miR-637 Prevents Glioblastoma Progression by Interrupting ZEB2/WNT/beta-catenin Cascades. Wang W, Zhao Z, Han S, Wu D. Cell Mol Neurobiol. 2021 May 28. pii: 10.1007/s10571-021-01107-1. doi: 10.1007/s10571-021-01107-1. PubMed
Essentiality of CTNNB1 in Malignant Transformation of Human Embryonic Stem Cells under Long-Term Suboptimal Conditions. Liu J, Zeng S, Wang Y, Yu J, Ouyang Q, Hu L, Zhou D, Lin G, Sun Y. Stem Cells Int. 2020 Sep 24;2020:5823676. doi: 10.1155/2020/5823676. eCollection 2020. PubMed
RNA helicase p68 deploys beta-catenin in regulating RelA/p65 gene expression: implications in colon cancer. Khare V, Tabassum S, Chatterjee U, Chatterjee S, Ghosh MK. J Exp Clin Cancer Res. 2019 Jul 27;38(1):330. doi: 10.1186/s13046-019-1304-y. PubMed
beta-catenin decreases acquired TRAIL resistance in non-small-cell lung cancer cells by regulating the redistribution of death receptors. You C, Zhang S, Sun Y, Zhang S, Tang G, Tang F, Liu X, Xiao Y, Zhang J, Gong Y, Xie C. Int J Oncol. 2018 Nov;53(5):2258-2268. doi: 10.3892/ijo.2018.4529. Epub 2018 Aug 21. PubMed
Wnt signal activation induces midbrain specification through direct binding of the beta-catenin/TCF4 complex to the EN1 promoter in human pluripotent stem cells. Kim JY, Lee JS, Hwang HS, Lee DR, Park CY, Jung SJ, You YR, Kim DS, Kim DW. Exp Mol Med. 2018 Apr 13;50(4):24. doi: 10.1038/s12276-018-0044-y. PubMed
FOXQ1 controls the induced differentiation of melanocytic cells. Bagati A, Bianchi-Smiraglia A, Moparthy S, Kolesnikova K, Fink EE, Kolesnikova M, Roll MV, Jowdy P, Wolff DW, Polechetti A, Yun DH, Lipchick BC, Paul LM, Wrazen B, Moparthy K, Mudambi S, Morozevich GE, Georgieva SG, Wang J, Shafirstein G, Liu S, Kandel ES, Berman AE, Box NF, Paragh G, Nikiforov MA. Cell Death Differ. 2018 Jun;25(6):1040-1049. doi: 10.1038/s41418-018-0066-y. Epub 2018 Feb 20. PubMed
Dual inhibition of Wnt and Yes-associated protein signaling retards the growth of triple-negative breast cancer in both mesenchymal and epithelial states. Sulaiman A, McGarry S, Li L, Jia D, Ooi S, Addison C, Dimitroulakos J, Arnaout A, Nessim C, Yao Z, Ji G, Song H, Gadde S, Li X, Wang L. Mol Oncol. 2018 Apr;12(4):423-440. doi: 10.1002/1878-0261.12167. Epub 2018 Feb 21. PubMed
Ectopic Expression of Snail and Twist in Ph+ Leukemia Cells Upregulates CD44 Expression and Alters Their Differentiation Potential. Kidan N, Khamaisie H, Ruimi N, Roitman S, Eshel E, Dally N, Ruthardt M, Mahajna J. J Cancer. 2017 Oct 23;8(19):3952-3968. doi: 10.7150/jca.19633. eCollection 2017. PubMed
APC downregulated 1 inhibits breast cancer cell invasion by inhibiting the canonical WNT signaling pathway. Cho SG. Oncol Lett. 2017 Oct;14(4):4845-4852. doi: 10.3892/ol.2017.6801. Epub 2017 Aug 23. PubMed

If you have published an article using this material, please email us at help@addgene.org to have your article added to this page.